Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：5.6 Date：2024-02-07

Frontiers in Pharmacology

Overexpression of CXCL17 increases migration and invasion of A549 lung adenocarcinoma cells

Products： ELK3130
IF：5.6 Date：2024-05-20

Journal of Functional Foods

Effect of soluble dietary fiber on gut microbiota and derived metabolites in stage 3 to 5 chronic kidney disease patients: A randomized controlled trial

Products： ELK8356
IF：5.6 Date：2024-05-17

Frontiers in Pharmacology

Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway

Products： ELK1129、 ELK1194、 ELK1195
IF：5.6 Date：2023-11-27

International Immunopharmacology

Dapagliflozin alleviates arsenic trioxide-induced hepatic injury in rats via modulating PI3K/AkT/mTOR, STAT3/SOCS3/p53/MDM2 signaling pathways and miRNA-21, miRNA-122 expression

Products： ELK1144、 ELK1158、 ELK1272、 ELK1396、 ELK1477、 ELK2600

< Page of 331 >